White Eyes

White Eyes
Name	White Eyes
Field	Ophthalmology
Symptoms	Blanched conjunctiva, periorbital pallor, vision changes
Complications	Corneal ulceration, vision loss
Medication	Topical antibiotics, antivirals, corticosteroids (specialist-prescribed)
Specialty	Ophthalmology, Emergency medicine

White Eyes

White Eyes is a colloquial term used in clinical practice to describe an appearance of marked paleness of the ocular surface and periocular tissues associated with various underlying causes. The term appears in literature and clinical notes across Ophthalmology, Emergency medicine, and Pediatrics contexts to denote conspicuous conjunctival blanching or pallor that may signal systemic or local pathology. Recognition often prompts urgent evaluation by specialists from Ophthalmology and referrals to services such as Hematology, Infectious disease, or Critical care medicine.

Definition and Terminology

The designation White Eyes denotes a visual phenotype rather than a single disease entity, traditionally described alongside other eponyms and syndromic labels in Ophthalmology and Pediatrics case series. Clinicians may record the sign during triage in Emergency department notes, in outpatient settings like General practice or specialty clinics including Cornea service and Oculoplastics clinic. Comparable descriptive terms appear in literature from institutions such as Mayo Clinic, Johns Hopkins Hospital, and Great Ormond Street Hospital. The term is distinct from named diagnoses found in classification systems used by World Health Organization or coding systems like the International Classification of Diseases.

Causes and Pathophysiology

Multiple mechanisms produce the white or blanched ocular appearance. Hematologic causes, including severe iron deficiency anemia and aplastic anemia documented by Hematology studies, reduce conjunctival vascularity. Vascular causes such as vasospasm in conditions investigated by Cardiology and Rheumatology (e.g., systemic vasculitides evaluated by tests used at Cleveland Clinic) can transiently pallor ocular tissues. Infectious agents studied in Infectious disease—notably viral keratoconjunctivitis from pathogens tracked by Centers for Disease Control and Prevention and bacterial infections encountered at Public Health England clinics—can produce surface desiccation and keratitis leading to a pale appearance. Iatrogenic and drug-induced etiologies involve vasoconstrictors administered in Anesthesiology or ophthalmic preparations reviewed in Food and Drug Administration advisories. Structural causes, including severe conjunctival scarring from conditions managed by Cornea service and autoimmune diseases seen by Rheumatology (for example, Sjögren syndrome evaluated at Mayo Clinic), alter normal vascular patterns.

Clinical Presentation and Diagnosis

Patients present to settings such as Emergency department or Ophthalmology clinic with complaints that prompt visual inspection by clinicians from Primary care and Pediatrics. Typical findings documented in case reports from British Journal of Ophthalmology include pallor of palpebral conjunctiva, reduced conjunctival injectivity, and associated symptoms like epiphora or photophobia assessed during slit-lamp examination in Ophthalmology units. Diagnostic pathways often involve laboratory testing ordered by Hematology (complete blood count), microbiology cultures guided by Infectious disease, imaging performed in Radiology (orbital ultrasound or CT), and bedside procedures by Clinical pathology services. Specialized tests from Immunology or genetic panels in Genetics clinics are used when autoimmune or hereditary syndromes are suspected.

Differential Diagnosis

Differential considerations overlap services across Ophthalmology, Hematology, Infectious disease, and Rheumatology. Conditions commonly considered include conjunctival pallor due to anemia referenced in Hematology guidelines, keratoconjunctivitis sicca as managed in Rheumatology and Ophthalmology, ischemic ocular syndromes investigated by Vascular surgery and Cardiology, and iatrogenic blanching related to vasoconstrictor exposure reviewed by Pharmacology and Anesthesiology. Other entities in specialty literature, such as scleral icterus from hepatobiliary disorders handled by Gastroenterology and orbital cellulitis treated by Otolaryngology and Infectious disease, are differentiated by targeted assessment.

Management and Treatment

Initial management emphasizes stabilization in Emergency medicine when systemic compromise is suspected, with coordinated care involving Ophthalmology and Hematology or Infectious disease as indicated. Evidence-based interventions documented in clinical practice at centers like Massachusetts General Hospital include topical antimicrobial regimens endorsed by Infectious disease guidelines, hematinic therapy directed by Hematology protocols for iron deficiency, and systemic immunomodulatory agents initiated under supervision of Rheumatology or Immunology for autoimmune causes. Procedural management—such as conjunctival biopsy performed by Ophthalmic surgery teams or orbital decompression coordinated with Neurosurgery and Oculoplastics—is reserved for specific structural etiologies described in surgical series.

Epidemiology and Risk Factors

Epidemiologic patterns are heterogeneous and described across cohorts in Pediatrics, Geriatrics, and adult Ophthalmology clinics. Risk factors reported in multicenter reviews from institutions such as Johns Hopkins Hospital and Mayo Clinic include chronic systemic disease managed in Endocrinology (e.g., diabetes mellitus), nutritional deficiencies identified by Public Health England surveillance, and prior exposure to topical vasoconstrictors regulated by Food and Drug Administration advisories. Geographic variation appears in case series from Africa, Asia, and Europe reflecting differing prevalences of infectious, hematologic, and autoimmune disorders tracked by regional public health agencies.

Prevention and Prognosis

Prevention strategies rely on primary care and specialty initiatives from Primary care, Ophthalmology, and Public Health England including screening for anemia per Hematology recommendations, vaccination campaigns promoted by Centers for Disease Control and Prevention, and stewardship of topical medications guided by Food and Drug Administration policy. Prognosis depends on underlying etiology: reversible causes such as iron deficiency treated per Hematology protocols often confer good visual outcomes reported in longitudinal studies from Mayo Clinic, whereas ischemic or scarring disorders managed by Ophthalmic surgery and Rheumatology carry variable long-term visual morbidity documented in specialty registries.

Category:Ophthalmology